122 related articles for article (PubMed ID: 24998095)
1. Pharmacokinetics and tolerability of aminosidine after repeated administrations using an optimal dose regimen in healthy dogs and in dogs with leishmaniosis.
Athanasiou LV; Batzias GC; Saridomichelakis MN; Delis G; Soubasis N; Kontos VI; Rallis TS
Vet Parasitol; 2014 Sep; 205(1-2):365-70. PubMed ID: 24998095
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
[TBL] [Abstract][Full Text] [Related]
3. Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.
Athanasiou LV; Saridomichelakis MN; Kontos VI; Spanakos G; Rallis TS
Vet Parasitol; 2013 Feb; 192(1-3):91-7. PubMed ID: 23140991
[TBL] [Abstract][Full Text] [Related]
4. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and dosing regimen of aminosidine in the dog.
Belloli C; Crescenzo G; Carli S; Villa R; Sonzogni O; Carelli G; Ormas P
Vet Res Commun; 1996; 20(6):533-41. PubMed ID: 8950834
[TBL] [Abstract][Full Text] [Related]
6. Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
Belloli C; Crescenzo G; Carli S; Zaghini A; Mengozzi G; Bertini S; Ormas P
Vet J; 1999 May; 157(3):315-21. PubMed ID: 10328843
[TBL] [Abstract][Full Text] [Related]
7. Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis.
Belloli C; Ceci L; Carli S; Tassi P; Montesissa C; De Natale G; Marcotrigiano G; Ormas P
Res Vet Sci; 1995 Mar; 58(2):123-7. PubMed ID: 7761689
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects.
Kanyok TP; Killian AD; Rodvold KA; Danziger LH
Antimicrob Agents Chemother; 1997 May; 41(5):982-6. PubMed ID: 9145856
[TBL] [Abstract][Full Text] [Related]
9. Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis.
Baneth G; Segev G; Mazaki-Tovi M; Chen H; Kuzi S
Parasit Vectors; 2018 Mar; 11(1):151. PubMed ID: 29554974
[TBL] [Abstract][Full Text] [Related]
10. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin).
Vexenat JA; Olliaro PL; Fonseca de Castro JA; Cavalcante R; Furtado Campos JH; Tavares JP; Miles MA
Am J Trop Med Hyg; 1998 Apr; 58(4):448-53. PubMed ID: 9574790
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
12. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis.
Koutinas AF; Saridomichelakis MN; Mylonakis ME; Leontides L; Polizopoulou Z; Billinis C; Argyriadis D; Diakou N; Papadopoulos O
Vet Parasitol; 2001 Jul; 98(4):247-61. PubMed ID: 11423183
[TBL] [Abstract][Full Text] [Related]
13. An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi).
Noli C; Saridomichelakis MN
Vet J; 2014 Dec; 202(3):425-35. PubMed ID: 25266647
[TBL] [Abstract][Full Text] [Related]
14. The first report of autochthonous non-vector-borne transmission of canine leishmaniosis in the Nordic countries.
Karkamo V; Kaistinen A; Näreaho A; Dillard K; Vainio-Siukola K; Vidgrén G; Tuoresmäki N; Anttila M
Acta Vet Scand; 2014 Dec; 56(1):84. PubMed ID: 25492266
[TBL] [Abstract][Full Text] [Related]
15. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
16. Canine leishmaniosis - an emerging disease.
Kaszak I; Planellas M; Dworecka-Kaszak B
Ann Parasitol; 2015; 61(2):69-76. PubMed ID: 26342500
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel biomarkers for treatment monitoring in canine leishmaniosis by high-resolution quantitative proteomic analysis.
Martinez-Subiela S; Horvatic A; Escribano D; Pardo-Marin L; Kocaturk M; Mrljak V; Burchmore R; Ceron JJ; Yilmaz Z
Vet Immunol Immunopathol; 2017 Sep; 191():60-67. PubMed ID: 28895868
[TBL] [Abstract][Full Text] [Related]
18. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs.
Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
Vet Parasitol; 2006 Feb; 135(3-4):347-54. PubMed ID: 16280198
[TBL] [Abstract][Full Text] [Related]
19. One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis.
Rougier S; Hasseine L; Delaunay P; Michel G; Marty P
Vet Parasitol; 2012 May; 186(3-4):245-53. PubMed ID: 22130335
[TBL] [Abstract][Full Text] [Related]
20. Detection of Leishmania infantum DNA by fret-based real-time PCR in urine from dogs with natural clinical leishmaniosis.
Solano-Gallego L; Rodriguez-Cortes A; Trotta M; Zampieron C; Razia L; Furlanello T; Caldin M; Roura X; Alberola J
Vet Parasitol; 2007 Jul; 147(3-4):315-9. PubMed ID: 17532143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
